Capstone Wealth Management Group (Oregon)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.7M Buy
11,026
+14
+0.1% +$3.26K 1.66% 19
2025
Q4
$2.28M Hold
11,012
1.38% 24
2025
Q3
$2.04M Buy
11,012
+273
+3% +$46.8K 1.3% 24
2025
Q2
$1.64M Buy
10,739
+118
+1% +$18.1K 1.19% 27
2025
Q1
$1.76M Buy
10,621
+221
+2% +$34.6K 1.41% 23
2024
Q4
$1.5M Buy
+10,400
New +$1.61M 1.14% 27

Other funds holding JNJ

Capstone Wealth Management Group (Oregon)'s JNJ Position: Q1 2026 in Review

Capstone Wealth Management Group (Oregon) increased its Johnson & Johnson (JNJ) stake by 0.13% in Q1 2026, buying an estimated $3.26K and bringing the position to 11,026 shares worth $2.7M. The position accounts for 1.66% of the portfolio, ranked #19.

Capstone Wealth Management Group (Oregon) first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Capstone Wealth Management Group (Oregon) held 11,026 shares of Johnson & Johnson worth $2.7M as of Q1 2026.
  • Capstone Wealth Management Group (Oregon) bought 14 Johnson & Johnson shares in Q1 2026, an estimated $3.26K.
  • Johnson & Johnson made up 1.66% of Capstone Wealth Management Group (Oregon)'s portfolio in Q1 2026, its #19 holding.
  • Capstone Wealth Management Group (Oregon) first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Capstone Wealth Management Group (Oregon)'s 13F filing for Q1 2026, filed 16 Apr 2026.